BNP Paribas Financial Markets Grows Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

BNP Paribas Financial Markets raised its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 3.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,336 shares of the company’s stock after acquiring an additional 729 shares during the period. BNP Paribas Financial Markets owned about 0.06% of Phibro Animal Health worth $548,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. CWM LLC boosted its position in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after buying an additional 1,035 shares during the period. nVerses Capital LLC purchased a new stake in Phibro Animal Health during the 3rd quarter valued at $70,000. Quantbot Technologies LP purchased a new position in shares of Phibro Animal Health in the third quarter worth approximately $70,000. Summit Securities Group LLC purchased a new position in shares of Phibro Animal Health during the 2nd quarter worth $83,000. Finally, China Universal Asset Management Co. Ltd. increased its holdings in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Bank of America lifted their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Friday, December 6th. Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $22.67 on Friday. Phibro Animal Health Co. has a 52 week low of $10.03 and a 52 week high of $25.98. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The firm has a market cap of $918.14 million, a P/E ratio of 52.72, a P/E/G ratio of 0.62 and a beta of 0.51. The business’s 50 day moving average price is $23.58 and its 200 day moving average price is $20.52.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.12%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s payout ratio is 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.